Latest news with #AFRO
Yahoo
25-06-2025
- Business
- Yahoo
Amesite's HIPAA Compliant NurseMagic™ App Now Operates in 16 Languages — Expanding Access to AI-Powered Charting for Nearly 1 Million U.S. Nurses
NurseMagic™ V3.0 uniquely addresses the needs of approximately 20% of U.S. nurses in the U.S. with AI-powered charting in their native language DETROIT, June 25, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced that its flagship app, NurseMagic™, now supports charting in 16 languages. This major enhancement is designed to address a key barrier to success for nearly 1 million nurses in the U.S. who speak English as a second language (ESL) — accounting for 19.2% of the nursing workforce — and to chart more efficiently and with greater confidence. This multilingual capability positions Amesite to meet immediate market needs. Markets now able to leverage the platform include: ESL nurses in the United States: Nearly 20% of U.S. nurses have English as a Second Language (ESL) International healthcare systems treating U.S. patients: There are over 6.5 Million nurses in the top 10 medical tourist destinations for U.S. patients alone. Private clinics in multilingual regions: The private sector provides nearly 40% of all healthcare in PAHO, AFRO, and WPRO regions, 57% in SEARO, and 62% in EMRO. Madison Bush, Director of Corporate Operations, said, 'This rollout reflects our disciplined approach to targeting segments with clear, documented needs — including the nearly one in five nurses in the U.S. who speak English as a second language. By addressing the needs of this workforce, who must document in English, we're positioned to capture value domestically and expand internationally.' Sai Nittala, Senior AI Manager, said, 'NurseMagic™ V3.0 delivers healthcare charting solutions that outperform generic, off-the-shelf AI tools. Unlike many unregulated or non-integrated solutions, NurseMagic™ is designed for seamless integration into critical healthcare workflows — where compliance, accuracy, and efficiency are essential. Our multilingual capability underscores our ability to scale rapidly while meeting real-world needs.'' Dr. Ann Marie Sastry, Founder & CEO, said, 'We have growing B2B traction following our launch of enterprise administration tools, and are also supporting B2C growth in new segments that prepare us for global expansion. As reported in our Q3 2025 10‑Q, we achieved a 2.4× quarter-on-quarter revenue increase while continuing to cut operating expenses. We believe we're on track for further revenue growth and cost efficiencies in coming quarters.' NurseMagic™ is Now Available In: English, Chinese, Hindi, Spanish, French, Portuguese, Russian, Indonesian, German, Japanese, Korean, Turkish, Italian, Ukrainian, Dutch, Swedish. Amesite recently announced a 2.4x quarter-over-quarter revenue increase in its 10-Q filing, driven by rapid adoption of its NurseMagic™ platform and improvements in operating efficiency. The company also launched a higher-priced enterprise tier in response to growing B2B demand for more capacity. In April, Amesite reported that NurseMagic™ meets HIPAA requirements for individual users and enterprises, enabling secure documentation of protected health information across all user types. About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagic™, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic™ is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations ir@ Sources in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25-06-2025
- Business
- Yahoo
Amesite's HIPAA Compliant NurseMagic™ App Now Operates in 16 Languages — Expanding Access to AI-Powered Charting for Nearly 1 Million U.S. Nurses
NurseMagic™ V3.0 uniquely addresses the needs of approximately 20% of U.S. nurses in the U.S. with AI-powered charting in their native language DETROIT, June 25, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced that its flagship app, NurseMagic™, now supports charting in 16 languages. This major enhancement is designed to address a key barrier to success for nearly 1 million nurses in the U.S. who speak English as a second language (ESL) — accounting for 19.2% of the nursing workforce — and to chart more efficiently and with greater confidence. This multilingual capability positions Amesite to meet immediate market needs. Markets now able to leverage the platform include: ESL nurses in the United States: Nearly 20% of U.S. nurses have English as a Second Language (ESL) International healthcare systems treating U.S. patients: There are over 6.5 Million nurses in the top 10 medical tourist destinations for U.S. patients alone. Private clinics in multilingual regions: The private sector provides nearly 40% of all healthcare in PAHO, AFRO, and WPRO regions, 57% in SEARO, and 62% in EMRO. Madison Bush, Director of Corporate Operations, said, 'This rollout reflects our disciplined approach to targeting segments with clear, documented needs — including the nearly one in five nurses in the U.S. who speak English as a second language. By addressing the needs of this workforce, who must document in English, we're positioned to capture value domestically and expand internationally.' Sai Nittala, Senior AI Manager, said, 'NurseMagic™ V3.0 delivers healthcare charting solutions that outperform generic, off-the-shelf AI tools. Unlike many unregulated or non-integrated solutions, NurseMagic™ is designed for seamless integration into critical healthcare workflows — where compliance, accuracy, and efficiency are essential. Our multilingual capability underscores our ability to scale rapidly while meeting real-world needs.'' Dr. Ann Marie Sastry, Founder & CEO, said, 'We have growing B2B traction following our launch of enterprise administration tools, and are also supporting B2C growth in new segments that prepare us for global expansion. As reported in our Q3 2025 10‑Q, we achieved a 2.4× quarter-on-quarter revenue increase while continuing to cut operating expenses. We believe we're on track for further revenue growth and cost efficiencies in coming quarters.' NurseMagic™ is Now Available In: English, Chinese, Hindi, Spanish, French, Portuguese, Russian, Indonesian, German, Japanese, Korean, Turkish, Italian, Ukrainian, Dutch, Swedish. Amesite recently announced a 2.4x quarter-over-quarter revenue increase in its 10-Q filing, driven by rapid adoption of its NurseMagic™ platform and improvements in operating efficiency. The company also launched a higher-priced enterprise tier in response to growing B2B demand for more capacity. In April, Amesite reported that NurseMagic™ meets HIPAA requirements for individual users and enterprises, enabling secure documentation of protected health information across all user types. About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagic™, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic™ is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations ir@ Sources
Zawya
10-06-2025
- Health
- Zawya
Lesotho leads Africa in health innovation: pilots Afro Influenza (AFFLU) Surveillance Platform
Lesotho has become the first nation in the WHO African Region to pilot the Afro Influenza (AFFLU) surveillance platform, a cutting-edge initiative aimed at boosting the country's health surveillance system. This platform, developed by the World Health Organization (WHO) for the African region as an adaptation of the Eastern Mediterranean (EMFLU) Influenza surveillance version, is designed to enhance the collection, management, and analysis of both aggregate and case-based data on influenza and other respiratory viruses (ORVs). The AFFLU platform represents a significant leap forward in the realm of health data management. It facilitates the sharing of epidemiological and virological data, streamlines data management processes, and improves data quality across all levels of the health system. Muza Tendai, Information Systems Specialist from the WHO Regional Office for Africa (AFRO), emphasized the transformative potential of this platform. "This surveillance platform will strengthen the country's respiratory disease surveillance and enable integration capabilities with other surveillance systems and datasets. It will provide real-time and advanced data analytics capabilities, customized to regional and country-specific contexts," Tendai stated. To ensure the successful implementation of the AFFLU platform, WHO has trained 18 end-users in Lesotho. These individuals are tasked with collecting and managing real-time data at four selected surveillance sites within and beyond the Maseru district. This training is crucial for the effective operation of the platform and the accurate collection of data. Dr. Lieketseng Petcane, representing the Director General of Health Services at the Lesotho Ministry of Health, expressed her enthusiasm for the initiative. "It is exciting that we are the first pilot country of this surveillance platform in our region. COVID-19 taught us many lessons, and diagnostics were a major challenge during that time. It revealed the gaps and areas that we needed to address. This platform will strengthen our surveillance and response. This will boost our human resource capabilities as well," Dr. Petcane remarked. The AFFLU platform is expected to have a profound impact on Lesotho's health surveillance system. Malefane Thamae, Maseru District Surveillance Officer, highlighted the benefits of this development. "This will help us in the early detection of an outbreak, hence improved Rapid Response to affected areas. It will provide our office with rapid access to countermeasures, such as the provision of appropriate vaccines," Thamae explained. Lesotho's pioneering efforts in piloting the AFFLU surveillance platform underscore the country's commitment to advancing its health infrastructure. By leveraging this innovative technology, Lesotho is poised to enhance its capacity to respond to respiratory diseases, ultimately improving public health outcomes for its citizens. As the pilot program progresses, the insights gained from Lesotho's experience will be invaluable for other African nations looking to adopt similar surveillance tools. The AFFLU platform not only represents a significant technological advancement but also a promising development for improved health surveillance and response across the continent. Distributed by APO Group on behalf of World Health Organization (WHO) - Lesotho.
